Harary Paul M, Jgamadze Dennis, Kim Jaeha, Wolf John A, Song Hongjun, Ming Guo-Li, Cullen D Kacy, Chen H Isaac
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA 19104, USA.
Brain Sci. 2023 Nov 29;13(12):1654. doi: 10.3390/brainsci13121654.
Neural transplantation represents a promising approach to repairing damaged brain circuitry. Cellular grafts have been shown to promote functional recovery through "bystander effects" and other indirect mechanisms. However, extensive brain lesions may require direct neuronal replacement to achieve meaningful restoration of function. While fetal cortical grafts have been shown to integrate with the host brain and appear to develop appropriate functional attributes, the significant ethical concerns and limited availability of this tissue severely hamper clinical translation. Induced pluripotent stem cell-derived cells and tissues represent a more readily scalable alternative. Significant progress has recently been made in developing protocols for generating a wide range of neural cell types in vitro. Here, we discuss recent progress in neural transplantation approaches for two conditions with distinct design needs: Parkinson's disease and cortical injury. We discuss the current status and future application of injections of dopaminergic cells for the treatment of Parkinson's disease as well as the use of structured grafts such as brain organoids for cortical repair.
神经移植是修复受损脑回路的一种有前景的方法。细胞移植已被证明可通过“旁观者效应”和其他间接机制促进功能恢复。然而,广泛的脑损伤可能需要直接的神经元替代才能实现有意义的功能恢复。虽然胎儿皮质移植已被证明可与宿主脑整合并似乎发展出适当的功能特性,但这种组织存在的重大伦理问题和有限的可用性严重阻碍了其临床转化。诱导多能干细胞衍生的细胞和组织是一种更易于扩展的替代方案。最近在开发体外生成多种神经细胞类型的方案方面取得了重大进展。在这里,我们讨论针对两种具有不同设计需求的病症(帕金森病和皮质损伤)的神经移植方法的最新进展。我们讨论了多巴胺能细胞注射治疗帕金森病的现状和未来应用,以及使用诸如脑类器官等结构化移植物进行皮质修复的情况。